Accelerating response to antidepressant treatment in depression: A review and clinical suggestions

被引:54
|
作者
Nakajima, Shinichiro
Suzuki, Takefumi [2 ,3 ]
Watanabe, Koichiro
Kashima, Haruo
Uchida, Hiroyuki [1 ,2 ]
机构
[1] Keio Univ, Sch Med, Dept Neuropsychiat, Shinjuku Ku, Tokyo 1608582, Japan
[2] Ctr Addict & Mental Hlth, Geriatr Mental Hlth Program, Toronto, ON, Canada
[3] Univ Toronto, Dept Psychiat, Toronto, ON, Canada
关键词
Antidepressant; Early non-response; Major depressive disorder; Predictor; Switching; SEROTONIN REUPTAKE INHIBITOR; TREATING MAJOR DEPRESSION; EARLY IMPROVEMENT; PROMOTER POLYMORPHISM; DOUBLE-BLIND; METAANALYSIS; FLUOXETINE; DISORDER; EFFICACY; AUGMENTATION;
D O I
10.1016/j.pnpbp.2009.12.001
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective: The primary objective of this article is to review the literature regarding the speed of response to antidepressant drugs and potential strategies to accelerate the antidepressant response in new antidepressant-free patients with depression. Based on these data, we try to propose both an effective and safe antidepressant treatment strategy to alleviate depressive symptoms at the earliest opportunity. Data sources: Data were identified by searches of Medline (1966 to September 2009) and references from relevant articles and books. Search terms included depression, antidepressant, predictor, response, onset, acceleration, and augmentation. As our focus was on the acute phase treatment of depression, articles relevant to treatment-resistant depression were excluded. Only articles written in English or Japanese were consulted. Data selection: Studies, reviews, and books pertaining to the treatment of depression with a special regard to accelerating therapeutic effects were selected. Data synthesis: Most of the available treatment guidelines for major depressive disorders recommend the continuous use of antidepressants for 4 to 8 weeks based on the idea of a delayed onset of response to these drugs. Contrary to this conventional belief, the recent data indicate that antidepressants start to exert their effects within 2 weeks and early non-response could predict a subsequent unfavorable outcome. Conclusions: These findings suggest the need of revisiting the timing of an antidepressant switch for early non-responders, whereby switching could be commenced in as early as 2 weeks. (C) 2009 Elsevier Inc. All rights reserved.
引用
收藏
页码:259 / 264
页数:6
相关论文
共 50 条
  • [21] Systematic Review of Clinical Practice Guidelines for Failed Antidepressant Treatment Response in Major Depressive Disorder, Dysthymia, and Subthreshold Depression in Adults
    MacQueen, Glenda
    Santaguida, Pasqualina
    Keshavarz, Homa
    Jaworska, Natalia
    Levine, Mitchell
    Beyene, Joseph
    Raina, Parminder
    CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE, 2017, 62 (01): : 11 - 23
  • [22] Antidepressant treatment in bipolar depression: a vexing clinical problem
    Tundo, A.
    Cavalieri, P.
    JOURNAL OF PSYCHOPATHOLOGY, 2007, 13 (02): : 243 - 254
  • [23] Early changes in neural responses to emotional information predict clinical response to antidepressant treatment in depression
    Godlewska, B.
    Browning, M.
    Norbury, R.
    Cowen, P.
    Harmer, C.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2014, 17 : 82 - 82
  • [24] Peripheral cytokine levels and response to antidepressant treatment in depression: a systematic review and meta-analysis
    Liu, Jia Jia
    Wei, Ya Bin
    Strawbridge, Rebecca
    Bao, Yanping
    Chang, Suhua
    Shi, Le
    Que, Jianyu
    Gadad, Bharathi S.
    Trivedi, Madhukar H.
    Kelsoe, John R.
    Lu, Lin
    MOLECULAR PSYCHIATRY, 2020, 25 (02) : 339 - 350
  • [25] Peripheral cytokine levels and response to antidepressant treatment in depression: a systematic review and meta-analysis
    Jia Jia Liu
    Ya Bin Wei
    Rebecca Strawbridge
    Yanping Bao
    Suhua Chang
    Le Shi
    Jianyu Que
    Bharathi S. Gadad
    Madhukar H. Trivedi
    John R. Kelsoe
    Lin Lu
    Molecular Psychiatry, 2020, 25 : 339 - 350
  • [26] The Potential of Polygenic Risk Scores to Predict Antidepressant Treatment Response in Major Depression: A Systematic Review
    Meerman, Julia J.
    ter Hark, Sophie E.
    Janzing, Joost G. E.
    Coenen, Marieke J. H.
    JOURNAL OF AFFECTIVE DISORDERS, 2022, 304 : 1 - 11
  • [27] Value of early symptomatic response to antidepressant treatment in predicting treatment response in major depression
    Bulut, Sedar
    Bulut, Suheyla Dogan
    Ak, Emine
    Sengul, Melike Ceyhan Balci
    JOURNAL OF MOOD DISORDERS, 2015, 5 (03) : 113 - 119
  • [28] Phosphodiesterase genes and antidepressant treatment response: A review
    Esposito, Karin
    Reierson, Gillian W.
    Luo, Huai Rong
    Wu, Gui Sheng
    Licinio, Julio
    Wong, Ma-Li
    ANNALS OF MEDICINE, 2009, 41 (03) : 177 - 185
  • [29] Gene–Environment Interaction in Major Depression and Antidepressant Treatment Response
    Robert Keers
    Rudolf Uher
    Current Psychiatry Reports, 2012, 14 : 129 - 137
  • [30] DEPRESSION AND PANIC ATTACKS - RESPONSE TO ANTIDEPRESSANT DRUG-TREATMENT
    KAYSER, A
    ROBINSON, D
    YINGLING, K
    CORCELLA, J
    LAUX, D
    HOWARD, D
    INTERNATIONAL JOURNAL OF NEUROSCIENCE, 1987, 32 (1-2) : 430 - 430